Nyxoah SA

€0.75As of Sun 8 Nov 2026, 12:00 UTC
EBR:NYXHHealthcare
Country Belgium
PE (Fwd) •••
TSR 6Y CAGR (41.35%)
Div yield —
ROE (151.79%)
Medical Devices
Beta (5Y) 1.01
PE TTM —
TSR TTM (83.45%)
Mkt cap €76.79M
ROIC (52.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.95
26.02%
(55.88%)
Hold 1|1|10|5|1
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.01
0.01
0.01
0.01
34.32%
22.17%
18.24%
15.95%
Revenue€M
4.826
5.003
5.266
5.356
10.41%
11.03%
13.30%
11.12%
Peers (US$86.22M)
Cap (US$)
PE
16.16M
7.436x
Capital
TTM
5Y
10Y
Leveragex
0.789
(0.019)
—
EBIT/Intx
0.388
0.277
0.240
Own earn%
(19.03)
42.85
47.26
Sh yield%
13.87
34.83
38.47
Owners
Insiders/Inst%
1.30
25.14
Short interest%
2.51
SBC / revenue%
0.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
15–22
$1 testx
0.0
Incr. ROIC%
11